top of page
ABOUT
US
Redefining respiratory care through innovative tech solutions. Experience better breathing in patient-centric, tech-driven care.
OUR
MISSION
iRespitronics® pioneers patented aerosol respiratory tech for single patient use, with unique devices for simplified healthcare. Trusted across hospitals for all ages, it's the only CE approved handheld aerosol nebulizer available over-the-counter.
OUR
MISSION
iRespitronics®, LLC., stands as a global pioneer and developer of patented inline aerosol respiratory drug delivery technology for single patient use. Since its inception, iRespitronics' engineers have seamlessly integrated unique patented technologies, setting iRespitronics devices apart from any other product currently available in the market. iRespitronics has reimagined the Elite Pro, Elite, Elite Plus, Controller, and Flow Sensor, incorporating standard connectors designed to simplify and optimize the healthcare provider's tasks. iRespitronics' products find application across all departments within the hospital, catering to patients of all ages, from preemie babies to the elderly. Notably, iRespitronics holds the distinction of being the sole FDA-pending handheld aerosol nebulizer approved for over-the-counter sale.
OUR
TECHNOLOGY
At iRespitronics, innovation drives us. Our patented inline aerosol systems redefine reliability and performance for single patient use. Enhanced Elite series with standard connectors simplifies healthcare tasks, empowering professionals across all departments to deliver superior care to patients of all ages.
OUR
R&D
iRespitronics' R&D team is dedicated to advancing aerosol drug delivery tech. Innovation drives every product development initiative, supported by a structured five-stage gate development process for systematic and cost-effective project execution.
bottom of page